secwatch / observer
8-K filed January 10, 2025, 6:59 PM ET CIK 0001848437
other material confidence high sentiment negative materiality 0.80

Cartica Acquisition Corp: Nasdaq/NYSE listing notice — Cartica Acquisition Corp receives Nasdaq delisting notice; approves extension but sees large redemptions

Cartica Acquisition Corp

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.82

Cartica Acquisition Corp received a nasdaq delisting notice notice regarding other (rules IM-5101-2).

Exchange
nasdaq
Notice
delisting notice
Rules
IM-5101-2
Exact text from the filing
January 13, 2025 and (iii) a Form 25-NSE will be filed with the Securities and Exchange Commission (the “SEC”), which will remove the Company’s securities from listing and registration on Nasdaq. Under Rule IM-5101-2, a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its initial public offering registration statement. Since the Company failed to complete its initial business combination by January 4, 2025, the Staff concluded that the Company did not comply with Rule IM-5101-2 and that the Company’s securities are now
View on SEC.gov
Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Cartica Acquisition Corp received a nasdaq delisting notice notice regarding other (rules IM-5101-2).

Exchange
nasdaq
Notice
delisting notice
Rules
IM-5101-2
Exact text from the filing
January 6, 2025, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating that, pursuant to Nasdaq Listing Rule IM-5101-2 (“Rule IM-5101-2”), the staff of Nas
View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR
accession 0001104659-25-002306
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.